Eikon Therapeutics, Inc. (EIKN) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 44 days, typically, give or take 23 (last 4 releases)

Last 4 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Thu, Nov 12, 2026before open 43 8-K
Q2 FY2026Thu, Aug 13, 2026after close 44 8-K
Q1 FY2026Mon, May 11, 2026after close 41 8-K
Q4 FY2025Mon, Mar 30, 2026before open 89 8-K

What they guided beta

Q3 FY2026 "Ended third quarter 2026 with $461.7 million in cash, cash equivalents and marketable securities; updating runway guidance into the first quarter of 2028 based on continued fiscal discipline and operating leverage MILLBRAE, Calif., November 12, 2026 -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (Eikon), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today reported third quarter 2026 financial results and provided updates on its programs." exhibit
Q3 FY2026 "EIK1003: Eikon expects initial results from Cohort 1D of the ongoing Phase 1/2 study evaluating EIK1003 in combination with paclitaxel and platinum-based chemotherapy in the second half of 2027, and expects to complete the ongoing Phase 2 dose-optimization portion of the EIK1003 trial in the second half of 2027." exhibit
Q3 FY2026 "EIK1004: Eikon plans to initiate a combination arm in the Phase 1/2 study to evaluate EIK1004 with docetaxel in patients with castrate-resistant prostate cancer and expects to report initial results from that combination arm in the second half of 2027." exhibit
Q3 FY2026 "EIK1005: Eikon expects additional results from the Phase 1/2 study evaluating EIK1005 in combination with pembrolizumab in the first half of 2027 and complete results from the EIK1005 monotherapy portion of the trial in the second half of 2027." exhibit
Q3 FY2026 "EIK1006: Subject to FDA clearance, Eikon plans to initiate a Phase 1/2 study in metastatic prostate cancer and anticipates preliminary safety and efficacy data to be available in the second half of 2027." exhibit
Q2 FY2026 "o When combined with standard-of-care therapy, EIK1001 was observed to be associated with meaningful and consistent clinical activity across PD-(L)1 tumor proportion score subgroups o EIK1001 was observed to be generally well tolerated, permitting administration in the outpatient setting o Durable anti-tumor activity with median response duration of greater than 11 months for the non-squamous cohort was observed A more complete characterization of these durable responses will be presented at the ESMO Congress 2026 in October." exhibit
Q2 FY2026 "Preliminary safety, tolerability and pharmacokinetic data for EIK1005 will be presented on Friday, October 23 at the ESMO Congress 2026 in Madrid, Spain." exhibit
Q2 FY2026 "Eikon expects to submit an investigational new drug application (IND) for EIK1006 by the end of 2026." exhibit
Q2 FY2026 "EIK1006: Expects to submit an IND by the end of 2026." exhibit
Q2 FY2026 "Eikon expects its current cash, cash equivalents, and marketable securities to fund operations into the second half of 2027." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/EIKN
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/EIKN

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

EIKN earnings date badge

HTML

<a href="https://veritasdata.dev/company/EIKN/"><img src="https://veritasdata.dev/embed/EIKN.svg" alt="EIKN earnings date" width="240" height="56"></a>

Markdown

[![EIKN earnings date](https://veritasdata.dev/embed/EIKN.svg)](https://veritasdata.dev/company/EIKN/)

Script

<script async src="https://veritasdata.dev/embed/EIKN.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/EIKN"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.